Acute lung injury (ALI) and its more severe form, the acute respirato days of a predisposing insult. In this report we will consider tory distress syndrome (ARDS), are syndromes of acute respiratory ALI and ARDS together, although we also specifically refer failure that result from acute pulmonary edema and inflammation.
in ALI/ARDS, and management was exclusively expectant and supportive, reflecting major deficiencies in our underAcute lung injury (ALI) and the acute respiratory distress standing of the cellular and molecular nature, pathogenesis, syndrome (ARDS) are syndromes with a spectrum of increasand natural history of acute alveolar injury. Recently, howing severity of lung injury defined by physiologic and radioever, a prospective multicenter clinical trial demonstrated graphic criteria in which widespread damage to cells and structhat a lung-protective ventilatory strategy could substantially tures of the alveolar capillary membrane occurs within hours reduce mortality (5) . The results of this clinical trial suggest that there are additional opportunities to improve outcomes in ALI/ARDS if we can increase our fund of knowledge at the basic, translational, and clinical levels.
oping specific recommendations to be used by the NHLBI terial hypoxemia (Pa O 2 /Fi O 2 less than 300) and bilateral pulmonary opacities on the chest radiograph. Current definitions rein planning future research in ALI/ARDS. This article summarizes presentations and discussions at the Working Group quire exclusion of left atrial hypertension and overt heart failure by clinical assessment. It is often difficult to precisely distinguish meeting. The conference also considered trends and successes in other fields that may be instructive and relevant to ALI/ ALI/ARDS from other diffuse inflammatory conditions of the lung and, in some cases, from high-pressure pulmonary edema.
ARDS. As an example, management of patients with acute coronary syndromes has undergone major paradigm shifts in New diagnostic measures to address this issue would be useful. It is not yet clear how the physiologic alterations that define the recent years because of insights generated from fundamental, translational, and clinical investigation; this has resulted in clinical diagnosis of ALI/ARDS correlate with features that define the pathologic diagnosis, a constellation of histologic findings development of new interventional approaches and biologic and pharmacologic strategies that address thrombosis and termed diffuse alveolar damage (14) . Until recently, management of patients with ARDS was eninflammation in addition to a traditional focus on lipids and vascular remodeling and has generated ongoing investigatirely supportive with the objective of managing underlying infections medically and surgically, providing nutritional support, tions of these critical processes (6) (7) (8) . Similarly, a new treatment for severe sepsis, recombinant activated protein C, has and employing mechanical ventilation for acute respiratory failure. In a large prospective NHLBI-supported study, mortality was recently been developed based on molecular insights relevant to coagulation and inflammation that were then explored in reduced from 40 to 31% with the use of a ventilatory strategy that employed low Vt (6 ml/kg) and limited plateau pressure translational and clinical studies (9) (10) (11) . Sepsis is of particular interest because it is a leading predisposing condition that tient's ALI and raised interesting mechanistic questions concerning interaction of lung stretch and systemic injury that may
This report of the proceedings of the Working Group meeting begins with a brief overview of the clinical features provide additional therapeutic approaches. Also, the results of this trial raise interesting questions regarding how lung-protecof ALI/ARDS followed by sections that consider (1 ) gaps in our understanding of basic mechanisms underlying developtive ventilatory strategies work. For example, is the protection a result of decreased mechanical injury to the lung endothelium ment of ALI, (2 ) how genomics and proteomics may advance research in ALI/ARDS, (3 ) how genetic influences might be and epithelium, effects on the systemic compartment, or is there also a downregulation of proinflammatory stimuli for neutrophils studied in patients with ALI/ARDS, (4 ) the challenges posed by the heterogeneity of the clinical phenotypes in ALI/ and macrophages (15)? Also, are there beneficial effects from the change in the carbon dioxide tension, acid-base status, and ARDS, (5 ) how biological and clinical indices of lung injury may be useful, and (6 ) how animal models can be used to effects on reactive oxygen and nitrogen species?
Despite this advance in ventilation of patients with ALI/ARDS, provide insights into lung injury. The final section summarizes the major recommendations for future research directions.
considerable work is still needed to define the basic mechanisms that (1 ) initiate lung injury before institution of positive pressure
The group did not attempt to provide a comprehensive overview of the field, as there are many fine ones available (1, ventilation, (2 ) mediate progression of ongoing lung injury, (3 ) cause fibrosing alveolitis and pulmonary hypertension with ex-12); instead, citations outside of the field are highlighted. The report reflects common opinions of the participants. The chaltensive obliteration of the lung circulation in subsets of patients, and (4 ) mediate the propagation of injury from the lung to other lenges of ALI/ARDS remain substantial, and modern and evolving approaches in fundamental science (cell and molecorgans in many patients with ALI/ARDS. ular biology, genomics, proteomics, disease gene discovery) together with new approaches to clinical investigation pro-SYSTEMIC MANIFESTATIONS OF ALI/ARDS vide substantial opportunities to improve prevention, treat-A major feature of ALI/ARDS that distinguishes it from most ment, and outcomes in ALI/ARDS.
other lung diseases such as asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis is that ALI/ARDS
OVERVIEW OF ALI/ARDS
frequently has systemic components. Several of the major triggering conditions for ALI/ARDS, notably sepsis, nonpulmonary ALI/ARDS is a cause of acute respiratory failure that develops in patients of all ages from a variety of clinical disorders, includtrauma, and shock are systemic syndromes. Furthermore, diffuse injury and infection of the lung are major causes of systemic seping sepsis (pulmonary and nonpulmonary), pneumonia (bacterial, viral, and fungal), aspiration of gastric and oropharyngeal sis and the systemic inflammatory response syndrome and dysregulation of cellular responses in the lung may result in circulatcontents, major trauma, and several other clinical disorders including severe acute pancreatitis, drug overdose, and blood proding cytokines and other inflammatory and thrombotic mediators, as demonstrated in clinical studies and animal models (16) (17) (18) . ucts (1) . Most patients require assisted ventilation with positive pressure. The primary physiologic abnormalities are severe arteMany patients with refractory ALI/ARDS die of multiple organ dysfunction and/or sepsis, rather than isolated progressive respirial hypoxemia as well as a marked increase in minute ventilation secondary to a sharp increase in pulmonary dead space fraction. ratory failure (1) . A consensus of the working group was that ALI/ARDS is a Patients with ALI/ARDS develop protein-rich pulmonary edema resulting from exudation of fluid into the interstitial and airspace systemic syndrome in virtually all cases. It is important to investigate the cellular and molecular mechanisms that mediate pulmocompartments of the lung secondary to increased permeability of the barrier. Additional pathologic changes indicate that the mechnary injury responses to systemic insults, the factors that govern the participation of blood cells and humoral agents that mediate anisms involved in lung edema are complex and that edema is only one of the pathophysiologic events in ALI/ARDS. One physboth pulmonary and systemic injury, and mechanisms that govern compartmentalized injury in the lung versus dissemination iologic consequence is a significant decrease in lung compliance that results in an increased work of breathing (13) , one of the reato systemic sites and distant organs. Systemic responses to stress and injury are incompletely characterized but involve neural, sons why assisted ventilation is required to support most patients.
The clinical diagnosis of ALI is made by the presence of arendocrine, and pro-and anti-inflammatory mechanisms that may be either adaptive or pathologic (19) . Animal studies indicate thelium against experimental lung injury (24), but the mechanisms for this cytoprotective effect are not well understood. that neural stimulation modifies systemic responses to endotoxin and can differentially influence cytokine accumulation in the Lung Endothelium lung and in systemic tissues; this phenomenon involves vagal signaling of altered inflammatory cell function (20, 21) . MolecuThe responses of lung endothelial cells are also incompletely lar links that mediate interactions between the acute inflammadefined even though they appear to be the first cells of the lung tory system (innate immune effector mechanisms) and thromto be altered in ALI/ARDS triggered by sepsis, trauma, and botic and procoagulant responses are altered in stress and injury, other systemic conditions. The lung endothelium, in concert with as are interactions between innate and acquired immune rethe epithelial barrier, mediates the initial change in permeability sponses (19) .
and is also critical for repair and remodeling of the alveolar Signaling pathways, such as those provided by cytokines and capillary membrane. Endothelial heterogeneity may be a factor their receptors, may have protective or injurious effects dein the lung's responses to pathologic stimuli (25) . Each short segpending on the site of challenge and whether the inflammation ment of a rodent lung capillary possesses a few functionally disis local or systemic (22). The unknown aspects of these complex tinct endothelial cells-the pacemaker cells. These cells appear events are particularly relevant to ALI/ARDS that is induced to regulate endothelial calcium within the capillary segment by as a part of systemic disorders such as sepsis, multiple trauma, generating intercellular calcium waves, and they may be the sites and shock but also may be critical in order to understand the of inflammatory initiation in the capillary (26). More needs to pathologic responses to diffuse alveolar injury caused by direct be learned about the diversity of endothelial cells, particularly reinsults such as aspiration and microbial infection of the lung. garding how they regulate the onset of lung inflammation. Activation of endothelial cells, with functional changes that involve both new gene expression and constitutive pathways that do
CURRENT UNDERSTANDING AND SIGNIFICANT GAPS
not require new gene products, occurs in both pulmonary and
IN KNOWLEDGE
systemic endothelium (27). We have an incomplete picture of the The Working Group identified many areas in which there are molecular mechanisms that govern the responses of pulmonary significant knowledge gaps that must be addressed in order to endothelial cells, their interaction with alveolar epithelium, and facilitate progress in understanding ALI/ARDS and for devisthe responses of systemic endothelium in ALI/ARDS. ing new strategies for detection, prevention, management, and therapy.
Apoptosis, Necrosis, and Fibrosis
The cells of the alveolar capillary membrane together with A comprehensive understanding of the mechanisms of apoptosis cells of the innate immune and hemostatic systems are targets and necrosis in the initial injury and repair of lung epithelial of damage and effectors of injury in ALI/ARDS (1). The numand endothelial cells and other key cells involved in ALI/ARDS bers and morphologic phenotypes of these cells are altered in is lacking. These cellular processes are likely to be central to imdevelopment of ALI/ARDS and its progression or resolution balances between resolution and repair versus persistence and (14) . Although much has been learned about the cell biology of progression in ALI/ARDS and can be influenced by biomechanithe alveolar capillary membrane since the clinical syndrome of cal, inflammatory, and thrombotic stimuli (28). The mechanisms ALI/ARDS was described, the functional responses, biochemical that govern apoptosis and necrosis in endothelial and epithelial pathways, patterns of gene expression, molecular mechanisms of cells in the key phases of ALI/ARDS need definition. How apointeraction with other cells, and responses to injury remain inptosis and related cellular events influence fibrosing alveolitis, completely characterized and our understanding of these prowhich is an outcome in a subset of patients with ALI/ARDS, is cesses is embryonic at best. New approaches to ALI/ARDS are not known. Information is needed regarding signaling pathways, likely to require comprehensive understanding of the functions patterns of gene and protein expression, and functional responses of key interacting cells. New and evolving technologies and anain lung fibroblasts and mesenchymal cells that lead to dysregulytic methods may provide opportunities to fill knowledge gaps. lated matrix remodeling and relentless fibrosis in some patients with ALI/ARDS.
Lung Epithelium
It is unknown how lung endothelial and epithelial injury modThe important role of the alveolar epithelial barrier in the pathoify the fibrogenic response in ALI/ARDS or if apoptosis and genesis and resolution of ALI/ARDS has been increasingly apnecrosis affect the fibrotic process differently. Microarray analypreciated, including the role it plays in the production of surfacesis and assays of new protein expression using isolated cells in active material to maintain alveolar stability as well providing parallel with the study of animal models that include fibrosis are salt and water transport pathways for the resolution of alveolar likely to be revealing. New approaches to the cell and molecular edema. However, our understanding of the responses of the alvebiology of fibrogenesis that are being applied to the syndrome olar epithelium to injury remains incomplete. Disruption of alveof idiopathic pulmonary fibrosis may be useful in clarifying the olar epithelial integrity is a major contributor to increased pernature of alveolar fibrosis in ALI/ARDS. A caveat is that some meability and alveolar flooding with protein-rich edema fluid, a early events in ALI/ARDS do not involve new gene expression hallmark of ALI/ARDS (1). Understanding of molecular signalor changes in transcript level. Similarly, dissection of the cellular ing pathways and mechanisms of cell-cell interaction in alveolar and molecular processes involved in endothelial death versus epithelial cells at various stages after injury is rudimentary at repair and other key aspects of vascular wall remodeling will be best. Although it is clear that alveolar epithelial Type II cells recritical to understanding of the loss of pulmonary vessels and populate the injured, denuded alveolar barrier in ALI, very little the resultant pulmonary hypertension and the increase in alveois known about the intracellular signaling pathways that are aclar dead space that is also an outcome of a subset of patients tivated or differential mechanisms of gene expression during with ALI/ARDS. injury, proliferation, and differentiation. For example, we know An approach for the future treatment of ALI/ARDS could that epithelial cells produce cytokines in response to various stiminvolve stem cells to replace dying lung cells. A similar strategy uli such as LPS or lung stretch (23), but the regulatory features has been proposed for brain, heart, and liver diseases. The inare not completely defined. As a second example, specific mitoflammatory response includes release of cells from the bone marrow such as mature and immature neutrophils and stem cells. gens such as keratinocyte growth factor can protect the lung epi-Elegant bone marrow reconstitution studies have demonstrated cells, which recognize pathogen-associated molecular patterns in LPS and other microbial factors, are another group of factors that these stem cells have the potential to differentiate into endothelial, mesenchymal, and epithelial cells (29-31). The proliferathat are critical to inflammation and injury but were only recently discovered. Toll-like receptors are linked by intracellular signal tive potential of fully differentiated capillary endothelial cells and epithelial Type I cells is very poor in the lungs. The potential transduction cascades to activation of the nuclear factor-B family of transcription factors and induction of tumor necrosis factor for stem cells to help in the repair of injured lung tissue has not been explored and requires a better understanding of stem cell ␣ and other nuclear factor-B-dependent gene products. Their engagement is central to host defense and sepsis, septic shock, release, targeting, proliferation, and differentiation in lung tissue. Supplementing this release by intravenous infusion of donor and their complications including ALI/ARDS (44). The recent explosion of information regarding toll-like receptors illustrates bone marrow-derived stem cells might be useful in ALI/ARDS, as the pulmonary microvasculature would be the first capillary the point that much remains unknown regarding cellular responses and molecular signaling in the innate immune system. bed that these cells would encounter, enhancing their entrapment and accumulation. Newly implanted endothelial cells may Precise understanding of compartmentalized versus dysregulated systemic inflammation will depend on additional insights into the help restore the lung capillary network after ALI, although considerable work will be needed to develop approaches for delivery biology of these cells and the molecular systems that regulate them, including biologically active lipids, chemokines, and cytokines. of viable cells to injured areas of the lung.
Mechanical Forces and Lung Injury Thrombosis and Inflammation
Additional knowledge regarding the mechanisms that link acute There is incomplete understanding of how normal lungs deform during breathing and to what stresses key lung cells are exposed inflammatory responses to thrombosis and to activation of the coagulation cascade is also important because there is substantial (32). Lung injury may greatly alter these complex forces. Furthermore, there is uncertainty about the molecular mechanisms inevidence that microvascular thrombosis and dysregulated intravolved in mechanosensing and mechanotransduction (33). Recellular and extracellular fibrin deposition are early events in cent observations suggest that lung stretch induces local and/ ALI/ARDS and in experimental ALI (1, 45) . Recombinant actior systemic cytokine release (23), yet it remains unclear if the vated protein C, recently approved for treatment of severe sepsis, proinflammatory deformation response is a consequence of celinterrupts both inflammatory and thrombotic responses (10, 46, lular stress failure (34) or of stretch-mediated signal transduc-47). Recombinant platelet activating factor acetylhydrolase also tion. Integrated studies examining molecular pathways, individmay reduce mortality and organ failure in sepsis and trauma ual cellular responses, and responses of the intact lung will be and diminish inflammatory and thrombotic signaling (47) . The required to determine how mechanical ventilation modifies the development of both of these therapies can be traced to fundadynamic interactions of lung cells in ALI/ARDS. mental cell and molecular biology experiments in parallel with The effect of the mechanical stresses applied to the lung may preclinical animal studies. protein expressed in isolated cells or in complex tissues such as injured lung and also to determine posttranslational modifications, protein-
The toll-like receptors of innate immune cells and endothelial protein interactions, and other critical features that define phenotype or combinations of markers that can yet be used to define the and regulate cellular function (54 
GENETICS OF ALI/ARDS
and case-controlled association studies may be beneficial to explore in well-defined subgroups of patients with ALI/ARDS. A major gap in our knowledge is the extent to which genetic Positional cloning has been used with success in the study of features interact with environmental variables to influence suscomplex diseases. However, availability of the sequence of the ceptibility to ALI/ARDS. In sepsis, trauma, and other triggering human genome and new technologies that link gene discovery conditions, only a subset of patients develops ALI/ARDS even to biologic function will likely provide accelerated insight into among those in whom the pathologic stimuli are apparently multifactorial syndromes such as ALI/ARDS and will use new equivalent (1, 3, 5, 11), suggesting that there are genetic features that may influence its onset. Similarly, we do not know what geapproaches (66) . These include identification and establishment netic features influence the natural history of ALI/ARDS once of the significance of single-nucleotide polymorphisms and other it is established or how genetic variables interact with environvariations in the human genome; methods to further characterize mental factors to determine resolution and repair versus persisquantitative trait loci; identification of new pathways of cell functence and progression of acute lung inflammation and injury.
tion and regulation and refined analysis of known metabolic pathFurthermore, we have little understanding of genetic features ways based on coregulated genes; new analysis of mechanisms that regulate compartmentalization of inflammation and injury of transcriptional and posttranscriptional regulation, proteinin one case and engender a systemic response in another (19) .
protein interactions, and cross talk between signaling cascades; Human genetic syndromes are commonly classified as simple genotype-phenotype correlations that identify gene-gene interMendelian disorders or as multifactorial complex diseases. In actions and other modifying features that lead to variations in the Mendelian diseases, a mutation in one or both alleles of a single clinical phenotypes; and new approaches to dissecting interactions disease gene leads to a pathologic phenotype, whereas complex between genes and environment involving epidemiologic studies genetic syndromes are generally caused by mutations in more of carefully characterized populations. Robust databases that than one gene with significant contributions from the environlink disease records, family records, and other data sets that can be ment usually influencing the manifestations of the disease. Addiintegrated for biomedical research will be important tools. Applitional features of complex genetic diseases include large phenocation of the new genetic approaches will also require parallel retypic variation, incomplete penetrance, late age of onset, the finement of the clinical phenotypes of diseased patients and conpotential for locus heterogeneity, and lack of easily identified trol populations, a particular challenge in the case of ALI/ARDS. large families because of a complicated pattern of heritability.
Postgenomic approaches will continue to depend on genetiThe frequency of alterations in disease genes is variable in multically modified mice and other model systems. Mapping of traits, factorial disorders, potentially making them difficult to identify.
generation of knockouts and transgenics, and mutational strateRecent identification of alleles of the NOD 2 gene as variants gies with genome-wide analysis are highly tractable in mouse that predispose to Crohn's disease (56, 57) illustrates many of models and can circumvent some of the problems of human these points. Complex human disorders may also result from patient populations, including heterogeneity. Genetic and genomultiple rare variant mutations in a single gene leading to similar mic approaches using mice and other model species have promise or identical phenotypes (58) . Finally, many traits of clinical sigfor dissection of the complexity of cardiovascular diseases (67) nificance in complex diseases have continuous variation rather and other disorders. Some of these approaches have recently than discrete phenotypes; interacting genes that influence variabeen applied in mouse models of lung injury (68) . tion in these traits are located in chromosomal regions termed quantitative trait loci. Mapping quantitative trait loci to identify
HETEROGENEITY OF PHENOTYPE IN ALI/ARDS
genes involved in polygenic traits has been used for analysis of The heterogeneity of inciting factors and outcomes in ALI/ARDS complex human diseases, including asthma, arteriosclerosis, and creates complexity and uncertainty in the study of this syndrome. diabetes (59) .
In order to better understand specific mechanisms of ALI under In most cases, susceptibility to ALI/ARDS, and the natural different clinical conditions as well as to probe genetic and envihistory of these syndromes once they are established, is likely ronmental influences, it is important that more information be governed by genetic features together with environmental variobtained regarding characterization of subgroups of patients with ables in the complex fashion outlined previously. Studies of large ALI/ARDS. For example, the incidence, natural history, and families, evaluation of large archives of small families, and analyoutcome of ALI/ARDS induced by sepsis and trauma are quite sis of affected sibling pairs are major gene discovery approaches different in some senses, but the factors contributing to this that have been used in asthma and other complex diseases; howheterogeneity are not clear (1) . ever, these investigational tools are not available for ALI/ARDS.
Patients develop pneumonia from several different etiologies, Furthermore, there is substantial heterogeneity in ALI/ARDS (see next section), and there are no unique, easily measured markers including gram-positive or gram-negative bacteria, viruses, or even fungi or parasites, particularly in the presence of immunosupmains associated with cellular plasma membranes and is not released into solution (27). Thus, it may not be detected in pression, and the signaling pathways that regulate the inflammatory response to any particular organism depend on the initial bronchoalveolar lavage or other fluid samples and/or its concentration in fluid samples may bear little relationship to its signaling molecular interactions between the host cells and the organism (39, 44). A better understanding of bacterial genetics and the actions. Also, antigenic measurement of cytokines in edema fluid or bronchoalveolar lavage may not correlate well with biological specific virulence factors of infecting bacteria should provide new approaches to understanding susceptibility to pneumonia and activity. Both interleukin-␤ and tumor necrosis factor ␣ can be detected by immunoassays in the distal airspaces of the lung in ALI/ARDS both as a cause of injury and as a cause of nosocomial pneumonia in patients with ALI/ARDS (17). A better underpatients with early ALI, but interleukin-1␤ has more biological activity than tumor necrosis factor ␣ (70). standing of why some patients with sepsis develop ALI is needed. Is there a host susceptibility to sepsis so that patients who are more likely to upregulate gene expression for proinflammatory
ANIMAL MODELS OF LUNG INJURY
cytokines are therefore more likely to develop ALI? This hyAnimal studies that have attempted to mimic human ALI/ARDS pothesis is plausible but other factors may also be involved, such have been useful and will likely continue to provide valuable obas the ability of the host to confine an infection to a localized servations regarding both the mechanisms underlying the pathoarea. For example, the ability to mount a local proinflammatory genesis, progression, and resolution of this syndrome and ways response may be important in containing bacterial infection to in which its course can be modulated therapeutically (39, 68, one portion of the lung, thus preventing dissemination of cyto-71-76). The lack of an animal model that unequivocally mimics kines and bacterial products to the circulation that could result key aspects of human ALI/ARDS has been limiting in mechanisin multiple organ failure and diffuse lung injury if not locally tic studies and in providing meaningful and rapid extrapolations contained (19) . A more detailed understanding of the pathogeneto the clinical syndrome. Furthermore, there is uncertainty as sis of clinical lung injury, including biochemical markers, studies to which of the many available animal models best reflects the of lung pathology, and integrated studies using genomics and human clinical syndrome. Animal models are usually monitored proteomics may provide more insight into individual patient over a shorter term than the human syndrome, which requires susceptibility and potentially identify ALI/ARDS subgroups. It hours or days to develop. Most animal models do not include is possible that one or more specific markers may apply to one ventilation and fluid management interventions, features that phenotypic ALI/ARDS subgroup but not to another. Similar may be crucial factors in determining outcome in humans. A approaches are being used in other human diseases (55) .
major question is whether the pathogenesis of human ALI/ARDS varies with risk factors, such as trauma and sepsis. This has led
CLINICAL AND BIOCHEMICAL PREDICTORS OF ALI
to studies comparing and contrasting the mechanisms of injury in animal models of endotoxin and hemorrhagic shock-associated The search for biochemical and clinical predictors or markers of ALI has been hampered by a number of factors, including ALI (71). Administration of LPS alone does not completely mimic the systemic or pulmonary effects of bacteremia or endotoxemia, (1 ) the lack of correlation between the clinical diagnosis and the pathogenesis, (2 ) the recognition that patients at risk for and contributing to the use of more complex models such as cecal ligation and puncture (72). Furthermore, many workshop parwith ALI are heterogeneous, (3 ) the continuous discovery of new mediators and modulators of inflammation, (4 ) the recogniticipants suggested that two-hit models (73-76) might be more appropriate to reflect common comorbidities and risk factors tion that the development of ALI is likely the result of a balance of mediators and modulators of inflammation, and (5) the increascommonly present in these patients. Continued study of the heterogeneity of precipitating causes of ALI/ARDS is needed. ing awareness of the importance of correlating biochemical markers with physiologic variables. Although the recognition of these
The traditional knockout and transgenic approaches to delete or add a gene will remain useful, but more sophisticated approaches factors has complicated the quest for markers in ALI/ARDS, each of these factors provides unique new opportunities for their study.
to modify genes and to conditionally express or knock out genes are needed to better understand the role of particular molecules Patients with a higher severity of illness score are more likely to develop ALI/ARDS and die of lung injury. However, the and pathways (67) . In combination, these studies will elucidate interactions and redundancies in pathways and molecular funcsearch for a pulmonary-specific variable has been challenging. Indices of hypoxemia have not been predictive of clinical outtions. Furthermore, cell-and organ-specific approaches, either through bone marrow reconstitution or selection and manipulacome (5) . One recent study established that an elevated dead space fraction has an independent predictive power for identition of promoter function, will also prove valuable for understanding the complexities of cell function and interaction in the fying patients more likely to die (13) . This finding needs to be explored in conjunction with detailed biochemical studies and lungs and to provide potential therapeutic targets. Furthermore, animal studies can also facilitate understanding of the heterogeother methods to determine the pathologic and physiologic basis for a high dead space fraction. Procoagulant mechanisms are neity of phenotype using chemical mutagenesis or gene mapping and linkage studies in mice of specific genetic backgrounds that activated both in the circulation and the distal airspaces of the lung in patients with early ALI and may ultimately provide display variable responses to experimental lung injury. Finally, the availability of the rat genome will be extremely useful (77), markers of alveolar capillary damage or vascular occlusion (45) . More work is needed to evaluate products of endothelial injury as opportunities for comprehensive physiologic studies of lung injury are better in rats than in mice. as well as mechanisms that reflect endothelial, neutrophil, and thrombotic interactions. Markers of endothelial injury such as Animal models that facilitate "fast track" analysis of therapeutic leads and combinations of therapeutic agents would be von Willebrand factor that reflect pulmonary and systemic endothelial injury may prove useful.
expected to accelerate clinical application of basic discoveries. One approach that may prove useful for identifying clinical tarAlthough measurement of soluble biochemical markers in plasma, edema fluid, and bronchoalveolar lavage fluid has progets would involve gene profiling and proteomic evaluation of tissue from one or more animal models of lung injury that reflect vided insights into mechanisms of lung injury (69), they may not necessarily reflect critical molecular events at the cell surface.
phenotypic subgroups of ALI/ARDS. The effect of agents having the potential to diminish the severity of systemic and pulmonary In juxtacrine signaling between cells, the signaling molecule re-injury on genomic and proteomic variables could then provide 5. Future research should build in part on the recently demmechanistic insights to determine if similar pathways were being onstrated new treatments for ALI/ARDS and sepsis. altered in human ALI/ARDS and help to narrow the field of More basic research is needed to detail the cellular, mocandidate genes for human ALI/ARDS. Animal models could lecular, and physiologic mechanisms that protect the lung and should focus on both systemic and pulmonary injury and from biomechanical stress and injury and potentially may also provide insights about the interactions between them. modulate systemic inflammation. More studies are needed For example, recent studies of an intraperitoneal sepsis model in to explore the role of the inflammatory and coagulation rats using a limited gene microarray revealed interesting results pathways in inducing organ injury in sepsis and other regarding the host response in lung, kidney, brain, and lymphoid injury states and in modulating ALI. Both basic and clinitissues (72). Studies in animal models with clinical relevance to cal studies are needed. Although ARDS is a uniquely ALI/ARDS would facilitate the design of clinical trials focused human disease, animal models are relevant to several on diminishing clinical lung injury and the associated nonpulmodifferent features of clinical ALI. Better understanding nary organ dysfunction, including renal failure and hepatic and is needed to determine which animal models are most hematologic dysfunction, as well as the consequences of shock relevant to the human disease. "Two hit" models may states produced by sepsis and trauma.
better reflect comorbid conditions and other pre-existing variables and may be more informative in dissecting the
CONCLUSIONS AND RECOMMENDATIONS
roles of the innate immune system and specific mechanisms of lung injury. Animal models that focus on sysThere are major unanswered questions about ALI/ARDS that temic as well as pulmonary injury may prove to be particuwill require continued research efforts at the basic, translational, larly relevant to human ALI. Genetically altered mouse and clinical levels. Recent successes in the treatment of critically models will also be useful. Lung-and tissue-specific condiill patients provide an excellent opportunity for rapid progress, as tional knockouts, overexpression of candidate genes, and do new and evolving biologic, genomic and genetic approaches. Investigations and collaborative efforts that include cellular and other genetic models should be of value in dissecting mechanistic studies combined with animal and clinical studies the host response to pathological conditions that model will be the key to improving detection and treatment of this human lung injury. complex syndrome.
6. Because infection is the most frequent cause of ALI/ ARDS, the influence of bacterial and viral genetics on 1. Continued support for high quality collaborative multihost response that influence lung injury needs to be better center clinical trials, as well as individual investigatorunderstood. initiated studies, is crucial for continued progress in pre-7. Research to study and improve the resolution of ALI, vention and treatment of ALI/ARDS. Studies of multiple including mechanisms to modulate clearance of edema drug treatments for this complex syndrome may be needed.
fluid, soluble and insoluble proteins, inflammatory cells, Future studies could be broadened to include common comorbid conditions such as renal failure and sepsis. Supand remodeling of the lung is needed. The potential for port for mechanistic/pathogenic investigations in conenhancement of lung repair with stem cell therapy should junction with clinical trials is essential. The smaller clinical be explored. investigations conducted at single centers continue to 8. More emphasis is needed on understanding cell-to-cell have value because of complex patient populations and communication in the lung, including the mechanisms that to test new treatments for evidence to support further transmit signals between endothelial and epithelial cells evaluation in larger multicenter trials.
and mechanisms of cell-to-cell interaction in inflamma-2. Strategies for robust and facile analysis of genomic and tory and thrombotic responses. The signals and mechaproteomic data from studies in animal models, including nisms that determine normal cell turnover and influence genome sequencing databases, tissue-and species-specific apoptosis and necrosis in lung injury need to be elucimicroarrays, online archiving of serial microarray and dated. Advanced imaging modalities, such as microcomother data, and other resources should facilitate translaputerized tomography and confocal microscopy, should tion of animal experiments to clinical relevance.
be refined to generate data on cell and parenchymal mi-3. Studies that correlate biochemical and biological markers crostrains in intact lungs, so that molecular research on with clinical variables should continue in order to address mechanosensing and mechanotransduction can be interthe issue of heterogeneity, to more precisely define the preted in an appropriate context. Similarly, refined imphenotypes of patients with ALI/ARDS, to permit geaging techniques that are applicable to inflammatory cell netic analysis, and to facilitate clinical trials of new canditrafficking and cell-cell interactions will likely be infordate therapies. Panels of biological and biochemical markmative. ers, in conjunction with clinical indices, may be needed 9. Studies that use cell biological approaches including sinto generate a prognostic index in ALI/ARDS. Markers gle and multiple cell type cultures should be integrated that reflect systemic events (coagulation and inflammawith animal and human studies. tory markers) as well as those that reflect alterations in 10. More knowledge is needed to study the extent to which lung endothelial and epithelial cells and fibrotic processes genetic factors influence the development, severity and should be included. Pulmonary edema fluid, circulating time course of development and resolution of ALI/ARDS cells, DNA samples, and plasma should be obtained in as well as the development of multiple organ failure and clinical studies.
other systemic sequelae. Development of genetic tools and 4. Accrual and collections of well-characterized lung tissue resources specifically relevant to ALI/ARDS, triggering samples from patients with ALI/ARDS will facilitate apconditions, and systemic manifestations will likely faciliplication of modern analytic techniques (laser capture tate characterization of genetic and environmental varimicrodissection, microarray interrogation, proteomic analables that influence ALI. Case-control association studysis) to define the molecular phenotype of key lung cells and structures.
ies, although of lesser power, may be useful. 
